The prevalence, immunoglobulin class, and IgG-subclass of antireticulin antibody in the serum samples of 32 patients with systemic sclerosis were investigated by indirect immunofluorescence on unfixed rodent tissue.
Systemic sclerosis is a multisystem disorder of unknown aetiology characterised by abnormal deposition of collagen in the skin and internal organs, and microvascular obliteration, owing, in part, to intimal deposition of collagen.' 2 Circulating autoantibodies are a feature of systemic sclerosis, and include antibodies to various collagen types. 3 Reticulin is a connective tissue component which stains black using a silver impregnation technique4 and which closely resembles type III collagen.5 Autoantibodies to reticulin have been described in several disorders, and derive their name from the fact that with immunofluorescence on rodent tissue they give a 'reticular' pattern which corresponds to that of reticulin fibres obtained by silver impregnation. Several variants of these antibodies have been described on the basis of subtle differences in the immunofluorescence patterns.'
Antireticulin antibodies have not previously been described in systemic sclerosis, but we reasoned that a disease process characterised by the production of antibodies to collagen might also result in the formation of antireticulin antibody. We therefore investigated the prevalence, titre, immunoglobulin class, and IgG subclass of antireticulin antibody in patients with systemic sclerosis. (fig 3a) and the endothelial surfaces of large blood vessels in the kidney, leaving the tubules unstained (fig 3b) . The antibody used to detect collagen type III also stains the periphery of the portal tract but, in contrast with antireticulin antibody type 2, it stains the perimeter of tubules in an intermittent fashion and the perivascular aspects of large vessels with a characteristic cotton wool appearance (fig 4) .
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This study shows that antireticulin antibody is present in most patients with systemic sclerosis, and of particular interest is the comparatively high prevalence of IgA class antireticulin antibody.
We are not aware of previous reports describing antireticulin antibody in patients with systemic sclerosis and this may be owing, in part, to the variety of different techniques which can be used to investigate autoantibodies in the connective tissue disorders. Whereas the detection of antireticulin antibody requires the use of immunofluorescence on a substrate consisting of tissues from several organs, the study of autoimmune serology in systemic sclerosis has often focused on the fluorescence patterns of antinuclear antibodies,'I'7 which entails the use of cell lines such as HEp2 as substrate. As these are single cell preparations they do not allow the detection of connective tissue autoantibodies such as antireticulin. antireticulin production occurs at mucosal sites. This raises the intriguing possibility that there is an abnormal immune response to antigens presented to the immune system at the mucosal level in systemic sclerosis, resulting in the production of an IgA autoantibody.
An additional finding in this study is the relative IgGI subclass restriction of the antireticulin antibodies. Subclass restriction of autoantibodies has also been described in other connective tissue diseases. Anti-double-stranded DNA antibodies, for example, are predominantly of the IgGI and IgG3 subclasses in systemic lupus erythematosus. 22 In lupus the subclass restriction of autoantibodies has been ascribed to abnormalities of immune regulation,22 and a similar mechanism may prevail in systemic sclerosis.
The precise biochemical and structural nature of reticulin is not known, although a body of opinion holds that it is similar to type III collagen. 5 We compared the staining patterns of antireticulin antibodies and antibodies to the amino terminal propeptide of procollagen type III which is retained on mature type III collagen. 12 The patterns observed with antireticulin and this antibody in the portal tracts were similar, suggesting that they are directed against antigens which codistribute. In contrast, however, the differences seen in the staining in the kidney and large vessels indicate that the antigenic specificities of antireticulin antibody in systemic sclerosis and anticollagen type III are distinct.
In summary, this study reports the prevalence of antireticulin antibody, particularly of the IgA class, in patients with systemic sclerosis. The reactivity of antireticulin for collagen-like fibres suggests that the antibody arises as part of the disease process which leads to systemic sclerosis, while the fact that it belongs to the IgA class implies that it is elicited in response to antigens presented at the mucosal level. This might be a primary event with direct pathogenic relevance or a secondary, reactive phenomenon in keeping with the putative role of autoantibodies in the clearance of autoantigens.
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